Abstract

171P Combined expression of MKI67, FOXC1 and PDL1 is a pan-tumor tissue-agnostic predictor of PD1/PDL1 inhibitor efficacy in metastatic renal cell cancer: Validation in checkmate 009, 010 and 025 clinical trial cohorts

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The MRC Randomised-controlled Trial of Interferon-α, Interleukin-2 and 5-Fluorouracil vs Interferon-α Alone in Patients with Advanced Renal cell Carcinoma (RE04): Rationale and Progress
J.M.G Larkin ... M.E Gore
Clinical oncology (Royal College of Radiologists (Great Britain)) | VOL. 17
J.M.G Larkin, et. al.J.M.G Larkin ... M.E Gore
01 Aug 2005
The role of metastatectomy in metastatic renal cell cancer following the treatment with a molecular targeted agent.
R Levey ... R J Amato
Journal of Clinical Oncology | VOL. 28
R Levey, et. al.R Levey ... R J Amato
20 May 2010
Treatment of 283 Consecutive Patients With Metastatic Melanoma or Renal Cell Cancer Using High-Dose Bolus Interleukin 2
Steven A Rosenberg
JAMA | VOL. 271
Steven A RosenbergSteven A Rosenberg
23 Mar 1994
Tracking plasticity along with proliferation and immune evasion using FOXC1, MKI67 and PDL1 for prediction of therapeutic response and risk for hyperprogressive disease with PD1/PDL1 inhibitors in advanced/metastatic cancers: Pan-tumor validation in clinical trial and real-world cohorts.
Partha S Ray ... Robert Hussa
Journal of Clinical Oncology | VOL. 41
Partha S Ray, et. al.Partha S Ray ... Robert Hussa
01 Jun 2023
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022
R.A Freedman ... N.U Lin
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
R.A Freedman, et. al.R.A Freedman ... N.U Lin
06 Jul 2024
Primary tumor resection for asymptomatic colorectal cancer with unresectable metastasis: the end of the dilemma
Sebastiano Biondo ... Esther Kreisler
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Sebastiano Biondo, et. al.Sebastiano Biondo ... Esther Kreisler
03 Jul 2024
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
Elevating Cancer on the Global Health Agenda: Towards the 4th High-Level Meeting on NCDs 2025
Raffaella Casolino ... Andrè Ilbawi
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Raffaella Casolino, et. al.Raffaella Casolino ... Andrè Ilbawi
01 Jul 2024
View more papers